Comparison of infectious complications with BCMA-directed therapies in multiple myeloma - Quiz - MDSpire

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

  • By

  • Karthik Nath

  • Tala Shekarkhand

  • David Nemirovsky

  • Andriy Derkach

  • Bruno Almeida Costa

  • Noriko Nishimura

  • Tasmin Farzana

  • Colin Rueda

  • David J. Chung

  • Heather J. Landau

  • Oscar B. Lahoud

  • Michael Scordo

  • Gunjan L. Shah

  • Hani Hassoun

  • Kylee Maclachlan

  • Neha Korde

  • Urvi A. Shah

  • Carlyn Rose Tan

  • Malin Hultcrantz

  • Sergio A. Giralt

  • Saad Z. Usmani

  • Zainab Shahid

  • Sham Mailankody

  • Alexander M. Lesokhin

  • May 31, 2024

  • 0 min

Share

Original Source(s)

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

  • by Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi A. Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A. Giralt, Saad Z. Usmani, Zainab Shahid, Sham Mailankody, Alexander M. Lesokhin

  • May 31, 2024

Related Content

Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation

Exploring the Therapeutic Promise of γδ T Cells in Blood Disorders: Bridging Immunobiology and Clinical Innovation

Why are long-lived plasma cells long-lived?